secwatch.observer — SEC 8-K summary
======================================

Issuer:     Curanex Pharmaceuticals Inc (CURX)
CIK:        0002025942
Form:       8-K
Filed at:   2025-09-12T23:59:59+00:00
Accession:  0001493152-25-013167
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Curanex Pharma underwriters exercise full over-allotment; additional $2.25M raised
--------------------------------------------------------------------------------

- Over-allotment option exercised in full; 562,500 shares at $4.00, raising additional $2.25M.
- Total IPO gross proceeds: $17.25M from 4,312,500 shares.
- Shares outstanding after overallotment: 28,312,500.
- Lead underwriter Dominari Securities; co-underwriters Pacific Century and Revere.
- Company advances botanical drug Phyto-N for inflammatory diseases, targeting Phase I.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2025942/000149315225013167/0001493152-25-013167-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2025942/000149315225013167/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-013167

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer